Daniel Sinnett appointed Director of the Network of Applied Genetic Medicine

Daniel Sinnett, professor in the Department of Pediatrics and the Department of Biochemistry and Molecular Medicine, was appointed director of the Newtwork of Applied Genetic Medicine.

Daniel Sinnett, professor in the Department of Pediatrics and the Department of Biochemistry and Molecular Medicine, was appointed director of the Newtwork of Applied Genetic Medicine.

Credit: Claude Lacasse.

In 5 seconds

Daniel Sinnett, professor in the Department of Pediatrics and the Department of Biochemistry and Molecular Medicine, was appointed director of the Newtwork of Applied Genetic Medicine.

Dr. Daniel Sinnett, PhD, researcher and head of the Viral and immune disorders and cancers axis at CHU Sainte-Justine, and professor in the Department of Pediatrics and the Department of Biochemistry and Molecular Medicine at Université de Montréal, was appointed director of the Newtwork of Applied Genetic Medicine (RMGA), which is one of the thematic networks of the Fonds de recherche du Québec – Santé (FRQS).

His nomination reflects his roadmap as a leading figure in pediatric oncogenomics as well as CHU Sainte-Justine's strong position in human and medical genetics. ʺMy intention is to position the network as a key stakeholder that has a pivotal role to play in debates and policy-making regarding genetics and medical genomics in Quebecʺ, Sinnett says.

Dr. Guy Rouleau, MD, PhD, former RMGA Director and current Director of the Montreal Neurological Institute and Hospital, showed enthusiastic about the nomination. “Dr. Sinnett is an outstanding researcher, with invaluable expertise in the field of genetics. Through his leadership and commitment to the organisation over the last 10 years and in his role as an executive committee member, Dr. Sinnett has contributed greatly to the RMGA mission of advancing genetic discoveries from the bench to the clinic. I couldn't be more pleased to pass on role of Director to our esteemed colleague,” he said.

ʺI have witnessed how the RMGA has evolved, with the creation of strategic clusters, the achievement of a critical mass of researchers in various fields, and the emergence of genetic medicine-related issues – especially in this era of genomics – including, most unfortunately, economic challengesʺ, Sinnett recalls. In his new capacity, the scientist will strive to improve synergies among members in embracing today's realities. ʺThings are moving fast. We need to stay on top of the issues arising to ensure we maintain our leadership in Quebec.ʺ

With 103 members, the RMGA is among the largest FRQS networks in Quebec. It promotes the exchange and transfer of knowledge into services and approaches that benefit the Quebec population. It brings together a great variety of experts that are in a position to answer all matters of basic and applied research in human genetics.

Daniel Sinnett is holder of the François-Karl Viau Research Chair in Pediatric Oncogenomics, and he is a member and co-founder of the Robert Cedergren Centre for Bioinformatics and Genomics. His research focuses on the fields of genomics and pediatric cancer, especially deciphering the genetic and molecular mechanisms underlying childhood leukemia.

About the CHU Sainte-Justine Research Center

CHU Sainte-Justine Research Center is a leading mother-child research institution affiliated with the Université de Montréal. It brings together more than 200 research investigators, including over 90 clinicians, as well as 350 graduate and post-graduate students focused on finding innovative prevention means, faster and less invasive treatments, as well as personalized approaches to medicine. The Center is part of CHU Sainte-Justine, which is the largest mother-child center in Canada and second most important pediatric center in North America.